Startseite Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)

  • Marie-Christine W. Gast , Carla H. van Gils , Lodewijk F.A. Wessels , Nathan Harris , Johannes M.G. Bonfrer , Emiel J.Th. Rutgers , Jan H.M. Schellens und Jos H. Beijnen
Veröffentlicht/Copyright: 6. Mai 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Issues have been raised concerning the robustness and validity of alleged serum markers discovered by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Pre-analytical variables have been shown to exert a profound effect on protein profiles, irrespective of true biological variation. However, little is known about the possible effects of sample storage duration on protein profiles. We, therefore, aimed to investigate the effects of extended storage duration on the serum protein profile.

Methods: Archival sera from 140 breast cancer patients, stored at –30°C for 1–11 years, were profiled by SELDI-TOF MS using immobilised metal affinity capture (IMAC) arrays, a condition applied in the majority of breast cancer biomarker discovery studies.

Results: Fourteen peak clusters, structurally identified as C3a des-arginine anaphylatoxin and multiple fragments of albumin and fibrinogen, were found to be significantly associated with sample storage duration by five distinct patterns. These proteins have been described previously as potential cancer markers, rendering them specific to both disease and sample handling issues.

Conclusions: To prevent experimental variation being interpreted erroneously as disease associated variation, assessment of potential confounding pre-analytical parameters is a pre-requisite in biomarker discovery and validation studies. In addition, with respect to the different (non-)linear patterns observed in the current study, simply performing linear corrections to account for sample storage duration will not necessarily suffice.

Clin Chem Lab Med 2009;47:694–705.


Corresponding author: Ms. Marie-Christine Gast, Slotervaart Hospital, Department of Pharmacy and Pharmacology, P.O. Box 90440, 1006 BK Amsterdam, The Netherlands Phone: +31-20-512 5088, Fax: +31-20-512 4753,

Received: 2008-11-25
Accepted: 2009-3-5
Published Online: 2009-05-06
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. A focus on recent advances in proteomics – one step closer to entrance into the clinical arena
  3. Reviews
  4. Proteomics in protein misfolding diseases
  5. Multidimensional protein identification technology for clinical proteomic analysis
  6. Technical advances in proteomics mass spectrometry: identification of post-translational modifications
  7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
  8. Research Papers
  9. Thrombin induces broad spectrum proteolysis in human serum samples
  10. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
  11. Proteomics of exhaled breath: methodological nuances and pitfalls
  12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
  13. Approaching clinical proteomics: current state and future fields of application in fluid proteomics
  14. Genetics and Molecular Diagnostics
  15. Detection of Hpdel in healthy individuals and cancer patients in Taiwan
  16. Increased CA 19-9 level in patients without malignant disease
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
  19. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
  20. Reference Values and Biological Variations
  21. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties
  22. Systemic cytokine response following exercise-induced muscle damage in humans
  23. Letters to the Editor
  24. CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology
  25. Proficiency test of plasma free and total metanephrines: report from a study group
Heruntergeladen am 23.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.151/html?lang=de
Button zum nach oben scrollen